Literature DB >> 19939918

Cellular corepressor TLE2 inhibits replication-and-transcription- activator-mediated transactivation and lytic reactivation of Kaposi's sarcoma-associated herpesvirus.

Zhiheng He1, Yunhua Liu, Deguang Liang, Zhuo Wang, Erle S Robertson, Ke Lan.   

Abstract

Replication and transcription activator (RTA) encoded by open reading frame 50 (ORF50) of Kaposi's sarcoma-associated herpesvirus (KSHV) is essential and sufficient to initiate lytic reactivation. RTA activates its target genes through direct binding with high affinity to its responsive elements or by interaction with cellular factors, such as RBP-Jkappa, Ap-1, C/EBP-alpha, and Oct-1. In this study, we identified transducin-like enhancer of split 2 (TLE2) as a novel RTA binding protein by using yeast two-hybrid screening of a human spleen cDNA library. The interaction between TLE2 and RTA was confirmed by glutathione S-transferase (GST) binding and coimmunoprecipitation assays. Immunofluorescence analysis showed that TLE2 and RTA were colocalized in the same nuclear compartment in KSHV-infected cells. This interaction recruited TLE2 to RTA bound to its recognition sites on DNA and repressed RTA auto-activation and transactivation activity. Moreover, TLE2 also inhibited the induction of lytic replication and virion production driven by RTA. We further showed that the Q (Gln-rich), SP (Ser-Pro-rich), and WDR (Trp-Asp repeat) domains of TLE2 and the Pro-rich domain of RTA were essential for this interaction. RBP-Jkappa has been shown previously to bind to the same Pro-rich domain of RTA, and this binding can be subject to competition by TLE2. In addition, TLE2 can form a complex with RTA to access the cognate DNA sequence of the RTA-responsive element at different promoters. Intriguingly, the transcription level of TLE2 could be upregulated by RTA during the lytic reactivation process. In conclusion, we identified a new RTA binding protein, TLE2, and demonstrated that TLE2 inhibited replication and transactivation mediated by RTA. This provides another potentially important mechanism for maintenance of KSHV viral latency through interaction with a host protein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19939918      PMCID: PMC2812399          DOI: 10.1128/JVI.01984-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  80 in total

1.  A new Groucho TLE4 protein may regulate the repressive activity of Pax5 in human B lymphocytes.

Authors:  Michèle Milili; Laurent Gauthier; Julie Veran; Marie-Geneviève Mattei; Claudine Schiff
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

Review 2.  Molecular virology of Kaposi's sarcoma-associated herpesvirus.

Authors:  P S Moore; Y Chang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

3.  The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.

Authors:  M A Cotter; E S Robertson
Journal:  Virology       Date:  1999-11-25       Impact factor: 3.616

4.  Modelling transcriptional feedback loops: the role of Gro/TLE1 in Hes1 oscillations.

Authors:  Samuel Bernard; Branka Cajavec; Laurent Pujo-Menjouet; Michael C Mackey; Hanspeter Herzel
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2006-05-15       Impact factor: 4.226

5.  The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner.

Authors:  Subhash C Verma; Tathagata Choudhuri; Erle S Robertson
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

Review 6.  Kaposi's sarcoma-associated herpesvirus-encoded oncogenes and oncogenesis.

Authors:  P S Moore; Y Chang
Journal:  J Natl Cancer Inst Monogr       Date:  1998

Review 7.  Human herpesvirus-8: detection of novel herpesvirus-like DNA sequences in Kaposi's sarcoma and other lesions.

Authors:  O M Memar; P L Rady; S K Tyring
Journal:  J Mol Med (Berl)       Date:  1995-12       Impact factor: 4.599

8.  Molecular cloning and expression of mouse and human cDNA encoding AES and ESG proteins with strong similarity to Drosophila enhancer of split groucho protein.

Authors:  H Miyasaka; B K Choudhury; E W Hou; S S Li
Journal:  Eur J Biochem       Date:  1993-08-15

9.  Molecular interaction between TLE1 and the carboxyl-terminal domain of HES-1 containing the WRPW motif.

Authors:  D Grbavec; S Stifani
Journal:  Biochem Biophys Res Commun       Date:  1996-06-25       Impact factor: 3.575

10.  Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival.

Authors:  Farshid Dayyani; Jianfeng Wang; Jing-Ruey J Yeh; Eun-Young Ahn; Erica Tobey; Dong-Er Zhang; Irwin D Bernstein; Randall T Peterson; David A Sweetser
Journal:  Blood       Date:  2008-02-07       Impact factor: 22.113

View more
  18 in total

1.  Carboxyl-terminal amino acids 1052 to 1082 of the latency-associated nuclear antigen (LANA) interact with RBP-Jκ and are responsible for LANA-mediated RTA repression.

Authors:  Yi Jin; Zhiheng He; Deguang Liang; Quanzhi Zhang; Hongxing Zhang; Qiang Deng; Erle S Robertson; Ke Lan
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

2.  Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.

Authors:  Dhivya Ramalingam; Christine Happel; Joseph M Ziegelbauer
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

3.  Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.

Authors:  Bernadett Papp; Naeem Motlagh; Richard J Smindak; Seung Jin Jang; Aria Sharma; Juan D Alonso; Zsolt Toth
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

4.  Upregulation of cellular Bcl-2 by the KSHV encoded RTA promotes virion production.

Authors:  Jianming Gao; Qiliang Cai; Jie Lu; Hem Chandra Jha; Erle S Robertson
Journal:  PLoS One       Date:  2011-08-25       Impact factor: 3.240

5.  KSHV Rta Promoter Specification and Viral Reactivation.

Authors:  Jonathan Guito; David M Lukac
Journal:  Front Microbiol       Date:  2012-02-14       Impact factor: 5.640

6.  Suppressive regulation of KSHV RTA with O-GlcNAcylation.

Authors:  Ying-Chieh Ko; Wan-Hua Tsai; Pei-Wen Wang; I-Lin Wu; Shu-Yu Lin; Yu-Lian Chen; Jen-Yang Chen; Su-Fang Lin
Journal:  J Biomed Sci       Date:  2012-02-02       Impact factor: 8.410

Review 7.  KSHV reactivation and novel implications of protein isomerization on lytic switch control.

Authors:  Jonathan Guito; David M Lukac
Journal:  Viruses       Date:  2015-01-12       Impact factor: 5.048

8.  Fine-Tuning of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway.

Authors:  Shasha Li; Hao Hu; Zhiheng He; Deguang Liang; Rui Sun; Ke Lan
Journal:  PLoS Pathog       Date:  2016-10-19       Impact factor: 6.823

9.  NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway.

Authors:  Runna Ai; Yulin Sun; Zhimin Guo; Wei Wei; Lanping Zhou; Fang Liu; Denver T Hendricks; Yang Xu; Xiaohang Zhao
Journal:  Cancer Biol Ther       Date:  2016-07-14       Impact factor: 4.742

10.  ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.

Authors:  Jennifer J Wood; James R Boyne; Christina Paulus; Brian R Jackson; Michael M Nevels; Adrian Whitehouse; David J Hughes
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.